MeiraGTx Announces Preliminary Data From AQUAx Phase 1 Clinical Trial Of AAV-hAQP1 For Treatment Of Grade 2/3 Radiation-Induced Xerostomia by | Dec 7, 2021 | Extra Jobs | 0 comments Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Recent Comments